Annual report pursuant to Section 13 and 15(d)

Accrued Expenses (Tables)

v3.20.1
Accrued Expenses (Tables)
 12 Months Ended
Dec. 31, 2019
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses

Accrued expenses consisted of the following:

 

    December 31,  
    2019     2018  
Accrued clinical operations and trials costs   $ 14,242,669     $ 4,914,881  
Accrued product development costs     3,573,231       2,222,093  
Accrued compensation     3,673,111       2,253,621  
Accrued other     958,928       460,596  
Total   $ 22,447,939     $ 9,851,191